Li Peng
ORCID: 0009-0000-5017-1690
· 5 papers in corpus
lab-animal
2026
Endometriosis (EM) is an intractable gynecological condition with uncertain etiology. Gut microbiota have been increasingly implicated in EM, yet the underlying mechanisms remain unclear. Here, we identify a gut microbe-metabolite-uterus ax…
case-report
2025
We report a 67-year-old female diagnosed with ovarian mesonephric-like adenocarcinoma (MLA) and treated with a comprehensive regimen. This case emphasizes the urgent need for standardized diagnostic criteria and evidence-based treatment pro…
lab-animal
2023
Introduction: Dahuang-Taoren (DT) is a classic combination of botanical drugs applied to treat pain-related diseases in ancient China. Today, DT is frequently applied for dysmenorrhea of adenomyosis (AM) in the clinic. Growing evidence indi…
lab-animal
2023
BACKGROUND: "Rhubarb-Peach Kernel" herb pair (RP) one of the most frequently used drug pairs, has been used in traditional medicine in China to treat inflammation and diseases associated with pain. Although it is widely used clinically and …
case-report
2021
BACKGROUND: Meigs syndrome is a rare neoplastic disease characterized by the triad of benign solid ovarian tumor, ascites, and pleural effusion. In postmenopausal women with pleural effusions, ascites, elevated CA-125 level, and pelvic mass…